Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Am J Trop Med Hyg ; 2022 Feb 28.
Article in English | MEDLINE | ID: mdl-35226871

ABSTRACT

There is little information about the amount of recent tuberculosis transmission in low-income settings. Genetic clustering can help identify ongoing transmission events. A retrospective observational study was performed on Mycobacterium tuberculosis isolates from persons living with HIV (PLHIV) and HIV-seronegative participants who submitted samples to a referral tuberculosis laboratory in Guatemala City, Guatemala from 2010 to 2014. Genotyping results were classified according to the international spoligotyping database, SITVIT2. Spoligotype patterns were categorized as clustered or nonclustered depending on their genotype. The proportion of clustering and the index of recent transmission index (RTIn-1) were estimated. In the RTIn-1 method, clustered cases represent recent transmission, whereas nonclustered cases represent reactivation of older tuberculosis infections. As a secondary aim, the potential risk factors associated with clustering in isolates from the subset of participants living with HIV were explored. From 2010 to 2014, a total of 479 study participants were confirmed as culture-positive tuberculosis cases. Among the 400 available isolates, 71 spoligotype patterns were identified. Overall, the most frequent spoligotyping families were Latin American-Mediterranean (LAM) (39%), followed by T (22%) and Haarlem (14%). Out of the 400 isolates, 365 were grouped in 36 clusters (range of cluster size: 2-92). Thus, the proportion of clustering was 91% and the RTIn-1 was 82%. Among PLHIV, pulmonary tuberculosis was associated with clustering (OR = 4.3, 95% CI 1.0-17.7). Our findings suggest high levels of ongoing transmission of M. tuberculosis in Guatemala as revealed by the high proportion of isolates falling into genomic clusters.

2.
Malar J ; 20(1): 219, 2021 May 14.
Article in English | MEDLINE | ID: mdl-33990197

ABSTRACT

BACKGROUND: Insecticide-treated bed nets (ITNs) are widely used for the prevention and control of malaria. In Guatemala, since 2006, ITNs have been distributed free of charge in the highest risk malaria-endemic areas and constitute one of the primary vector control measures in the country. Despite relying on ITNs for almost 15 years, there is a lack of data to inform the timely replacement of ITNs whose effectiveness becomes diminished by routine use. METHODS: The survivorship, physical integrity, insecticide content and bio-efficacy of ITNs were assessed through cross-sectional surveys conducted at 18, 24 and 32 months after a 2012 distribution of PermaNet® 2.0 in a malaria focus in Guatemala. A working definition of 'LLIN providing adequate protection' was developed based on the combination of the previous parameters and usage of the net. A total of 988 ITNs were analysed (290 at 18 months, 349 at 24 months and 349 at 32 months). RESULTS: The functional survivorship of bed nets decreased over time, from 92% at 18 months, to 81% at 24 months and 69% at 32 months. Independent of the time of the survey, less than 80% of the bed nets that were still present in the household were reported to have been used the night before. The proportion of bed nets categorized as "in good condition" per World Health Organization (WHO) guidelines of the total hole surface area, diminished from 77% to 18 months to 58% at 32 months. The portion of ITNs with deltamethrin concentration less than 10 mg/m2 increased over time. Among the bed nets for which bioassays were conducted, the percentage that met WHO criteria for efficacy dropped from 90% to 18 months to 52% at 32 months. The proportion of long-lasting insecticidal nets (LLINs) providing adequate protection was 38% at 24 months and 21% at 32 months. CONCLUSIONS: At 32 months, only one in five of the LLINs distributed in the campaign provided adequate protection in terms of survivorship, physical integrity, bio-efficacy and usage. Efforts to encourage the community to retain, use, and properly care for the LLINs may improve their impact. Durability assessments should be included in future campaigns.


Subject(s)
Insecticide-Treated Bednets/statistics & numerical data , Malaria/prevention & control , Mosquito Control/statistics & numerical data , Cross-Sectional Studies , Guatemala
3.
Cytokine ; 125: 154818, 2020 01.
Article in English | MEDLINE | ID: mdl-31514106

ABSTRACT

The immune status of women changes during and after pregnancy, differs between blood compartments at delivery and is affected by environmental factors particularly in tropical areas endemic for multiple infections. We quantified the plasma concentration of a set of thirty-one TH1, TH2, TH17 and regulatory cytokines, pro-inflammatory and anti-inflammatory cytokines and chemokines, and growth factors (altogether biomarkers), in a cohort of 540 pregnant women from five malaria-endemic tropical countries. Samples were collected at recruitment (first antenatal visit), delivery (periphery, cord and placenta) and postpartum, allowing a longitudinal analysis. We found the lowest concentration of biomarkers at recruitment and the highest at postpartum, with few exceptions. Among them, IL-6, HGF and TGF-ß had the highest levels at delivery, and even higher concentrations in the placenta compared to peripheral blood. Placental concentrations were generally higher than peripheral, except for eotaxin that was lower. We also compared plasma biomarker concentrations between the tropical cohort and a control group from Spain at delivery, presenting overall higher biomarker levels the tropical cohort, particularly pro-inflammatory cytokines and growth factors. Only IL-6 presented lower levels in the tropical group. Moreover, a principal component analysis of biomarker concentrations at delivery showed that women from Spain grouped more homogenously, and that IL-6 and IL-8 clustered together in the tropical cohort but not in the Spanish one. Plasma cytokine concentrations correlated with Plasmodium antibody levels at postpartum but not during pregnancy. This basal profiling of immune mediators over gestation and in different compartments at delivery is important to subsequently understand response to infections and clinical outcomes in mothers and infants in tropical areas.


Subject(s)
Chemokines/blood , Cytokines/blood , Intercellular Signaling Peptides and Proteins/blood , Malaria/blood , Malaria/immunology , Plasmodium/immunology , Pregnancy Complications, Parasitic/blood , Adult , Brazil/epidemiology , Cohort Studies , Colombia/epidemiology , Female , Guatemala/epidemiology , Hepatocyte Growth Factor/blood , Humans , Immunoglobulin G/immunology , India/epidemiology , Interleukin-6/blood , Interleukin-8/blood , Malaria/parasitology , Papua New Guinea/epidemiology , Placenta/metabolism , Pregnancy , Pregnant Women , Spain , Transforming Growth Factor beta/blood
4.
PLoS Negl Trop Dis ; 11(6): e0005606, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28604825

ABSTRACT

BACKGROUND: Despite that over 90 million pregnancies are at risk of Plasmodium vivax infection annually, little is known about the epidemiology and impact of the infection in pregnancy. METHODOLOGY AND PRINCIPAL FINDINGS: We undertook a health facility-based prospective observational study in pregnant women from Guatemala (GT), Colombia (CO), Brazil (BR), India (IN) and Papua New Guinea PNG). Malaria and anemia were determined during pregnancy and fetal outcomes assessed at delivery. A total of 9388 women were enrolled at antennal care (ANC), of whom 53% (4957) were followed until delivery. Prevalence of P. vivax monoinfection in maternal blood at delivery was 0.4% (20/4461) by microscopy [GT 0.1%, CO 0.5%, BR 0.1%, IN 0.2%, PNG 1.2%] and 7% (104/1488) by PCR. P. falciparum monoinfection was found in 0.5% (22/4463) of women by microscopy [GT 0%, CO 0.5%, BR 0%, IN 0%, PNG 2%]. P. vivax infection was observed in 0.4% (14/3725) of placentas examined by microscopy and in 3.7% (19/508) by PCR. P. vivax in newborn blood was detected in 0.02% (1/4302) of samples examined by microscopy [in cord blood; 0.05% (2/4040) by microscopy, and 2.6% (13/497) by PCR]. Clinical P. vivax infection was associated with increased risk of maternal anemia (Odds Ratio-OR, 5.48, [95% CI 1.83-16.41]; p = 0.009), while submicroscopic vivax infection was not associated with increased risk of moderate-severe anemia (Hb<8g/dL) (OR, 1.16, [95% CI 0.52-2.59]; p = 0.717), or low birth weight (<2500g) (OR, 0.52, [95% CI, 0.23-1.16]; p = 0.110). CONCLUSIONS: In this multicenter study, the prevalence of P. vivax infection in pregnancy by microscopy was overall low across all endemic study sites; however, molecular methods revealed a significant number of submicroscopic infections. Clinical vivax infection in pregnancy was associated with maternal anemia, which may be deleterious for infant's health. These results may help to guide maternal health programs in settings where vivax malaria is endemic; they also highlight the need of addressing a vulnerable population such as pregnant women while embracing malaria elimination in endemic countries.


Subject(s)
Malaria, Vivax/complications , Plasmodium vivax , Pregnancy Complications, Parasitic/pathology , Adolescent , Adult , Brazil/epidemiology , Colombia/epidemiology , Female , Fetal Blood , Guatemala/epidemiology , Humans , India/epidemiology , Infant, Newborn , Infectious Disease Transmission, Vertical , Malaria, Vivax/epidemiology , Papua New Guinea/epidemiology , Pregnancy , Pregnancy Complications, Parasitic/epidemiology , Young Adult
5.
PLoS Negl Trop Dis ; 10(10): e0005009, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27711158

ABSTRACT

P. vivax infection during pregnancy has been associated with poor outcomes such as anemia, low birth weight and congenital malaria, thus representing an important global health problem. However, no vaccine is currently available for its prevention. Vir genes were the first putative virulent factors associated with P. vivax infections, yet very few studies have examined their potential role as targets of immunity. We investigated the immunogenic properties of five VIR proteins and two long synthetic peptides containing conserved VIR sequences (PvLP1 and PvLP2) in the context of the PregVax cohort study including women from five malaria endemic countries: Brazil, Colombia, Guatemala, India and Papua New Guinea (PNG) at different timepoints during and after pregnancy. Antibody responses against all antigens were detected in all populations, with PNG women presenting the highest levels overall. P. vivax infection at sample collection time was positively associated with antibody levels against PvLP1 (fold-increase: 1.60 at recruitment -first antenatal visit-) and PvLP2 (fold-increase: 1.63 at delivery), and P. falciparum co-infection was found to increase those responses (for PvLP1 at recruitment, fold-increase: 2.25). Levels of IgG against two VIR proteins at delivery were associated with higher birth weight (27 g increase per duplicating antibody levels, p<0.05). Peripheral blood mononuclear cells from PNG uninfected pregnant women had significantly higher antigen-specific IFN-γ TH1 responses (p=0.006) and secreted less pro-inflammatory cytokines TNF and IL-6 after PvLP2 stimulation than P. vivax-infected women (p<0.05). These data demonstrate that VIR antigens induce the natural acquisition of antibody and T cell memory responses that might be important in immunity to P. vivax during pregnancy in very diverse geographical settings.


Subject(s)
Antibodies, Protozoan/blood , Antigens, Protozoan/immunology , Immunoglobulin G/blood , Malaria, Vivax/immunology , Plasmodium vivax/immunology , Pregnancy Complications, Infectious/immunology , Th1 Cells/immunology , Adult , Birth Weight , Brazil/epidemiology , Cohort Studies , Coinfection/immunology , Coinfection/parasitology , Colombia/epidemiology , Cytokines/metabolism , Endemic Diseases , Female , Guatemala/epidemiology , Humans , Immunologic Memory , India/epidemiology , Interferon-gamma/metabolism , Leukocytes, Mononuclear/immunology , Malaria, Falciparum/immunology , Malaria, Vivax/epidemiology , Papua New Guinea/epidemiology , Plasmodium falciparum/genetics , Plasmodium falciparum/immunology , Plasmodium vivax/genetics , Plasmodium vivax/pathogenicity , Pregnancy , Pregnancy Complications, Infectious/epidemiology , Protozoan Proteins/genetics , Protozoan Proteins/immunology , Protozoan Proteins/isolation & purification
6.
PLoS One ; 11(3): e0152447, 2016.
Article in English | MEDLINE | ID: mdl-27011010

ABSTRACT

Plasmodium vivax is the most widely distributed human parasite and the main cause of human malaria outside the African continent. However, the knowledge about the genetic variability of P. vivax is limited when compared to the information available for P. falciparum. We present the results of a study aimed at characterizing the genetic structure of P. vivax populations obtained from pregnant women from different malaria endemic settings. Between June 2008 and October 2011 nearly 2000 pregnant women were recruited during routine antenatal care at each site and followed up until delivery. A capillary blood sample from the study participants was collected for genotyping at different time points. Seven P. vivax microsatellite markers were used for genotypic characterization on a total of 229 P. vivax isolates obtained from Brazil, Colombia, India and Papua New Guinea. In each population, the number of alleles per locus, the expected heterozygosity and the levels of multilocus linkage disequilibrium were assessed. The extent of genetic differentiation among populations was also estimated. Six microsatellite loci on 137 P. falciparum isolates from three countries were screened for comparison. The mean value of expected heterozygosity per country ranged from 0.839 to 0.874 for P. vivax and from 0.578 to 0.758 for P. falciparum. P. vivax populations were more diverse than those of P. falciparum. In some of the studied countries, the diversity of P. vivax population was very high compared to the respective level of endemicity. The level of inter-population differentiation was moderate to high in all P. vivax and P. falciparum populations studied.


Subject(s)
Genotype , Malaria/parasitology , Microsatellite Repeats , Plasmodium vivax/genetics , Alleles , Brazil , Colombia , Female , Genetic Markers , Genetic Variation , Genotyping Techniques , Geography , Haplotypes , Heterozygote , Humans , India , Linkage Disequilibrium , Papua New Guinea , Plasmodium falciparum/genetics , Polymerase Chain Reaction , Pregnancy , Pregnancy Complications, Infectious/parasitology
7.
Mil Med Res ; 2: 3, 2015.
Article in English | MEDLINE | ID: mdl-25722882

ABSTRACT

The Mesoamerican Ministers of Health have set 2020 as the target for malaria elimination to be achieved in the region. Imported malaria cases are a potential threat to countries attempting elimination or working to prevent resurgence. We report the first imported Plasmodium ovale infection with molecular confirmation in Central America, which occurred in a Guatemalan soldier that had been deployed in Africa. The obstacles for its diagnosis using the standard microscopy technique and the need to improve its detection are discussed.

8.
Malar J ; 11: 411, 2012 Dec 08.
Article in English | MEDLINE | ID: mdl-23217209

ABSTRACT

This is a report of the first Plasmodium vivax congenital malaria case in Guatemala and the first case in Latin America with genotypical, histological and clinical characterization. The findings show that maternal P. vivax infection still occurs in areas that are in the pathway towards malaria elimination, and can be associated with detrimental health effects for the neonate. It also highlights the need in very low transmission areas of not only maintaining, but increasing awareness of the problem and developing surveillance strategies, based on population risk, to detect the infection especially in this vulnerable group of the population.


Subject(s)
Malaria, Vivax/congenital , Endemic Diseases , Female , Fetal Blood/parasitology , Guatemala/epidemiology , Humans , Infant, Newborn , Infectious Disease Transmission, Vertical , Malaria, Vivax/epidemiology , Malaria, Vivax/transmission , Parasitemia/congenital , Parasitemia/parasitology , Plasmodium vivax/genetics , Plasmodium vivax/isolation & purification , Population Surveillance , Pregnancy , Pregnancy Complications, Parasitic/epidemiology , Pregnancy Complications, Parasitic/parasitology , Young Adult
9.
J Ethnopharmacol ; 142(1): 259-64, 2012 Jun 26.
Article in English | MEDLINE | ID: mdl-22580039

ABSTRACT

AIM OF THE STUDY: We use the IDM model to test for over- and underuse of plant taxa as source for medicine. In contrast to the Bayes approach, which only considers the uncertainty around the data of medicinal plant surveys, the IDM model also takes the uncertainty around the inventory of the flora into account, which is used for the comparison between medicinal and local floras. MATERIALS AND METHODS: Statistical analysis of the medicinal flora of Campania (Italy) and of the medicinal flora used by the Sierra Popoluca (Mexico) was performed with the IDM model and the Bayes approach. For Campania 423 medicinal plants and 2237 vascular plant species and for the Sierra Popoluca 605 medicinal plants and 2317 vascular plant species were considered. RESULTS: The IDM model (s=4) indicates for Campania the Lamiaceae and Rosaceae as overused, and the Caryophyllaceae, Poaceae, and Orchidaceae as underused. Among the Popoluca the Asteraceae and Piperaceae turn out to be overused, while Cyperaceae, Poaceae, and Orchidaceae are underused. In comparison with the Bayes approach, the IDM approach indicates fewer families as over- or underused. CONCLUSIONS: The IDM model leads to more conservative results compared to the Bayes approach. Only relatively few taxa are indicated as over- or underused. The larger the families (n(j)'s) are, the more similar do the results of the two approaches turn out. In contrast to the Bayes approach, small taxa with most or all species used as medicine (e.g., n(j)=2, x(j)=2) tend not to be indicated as overused with the IDM model.


Subject(s)
Models, Statistical , Plants, Medicinal/classification , Bayes Theorem , Italy , Medicine, Traditional , Mexico , Probability , Uncertainty
10.
J Int Acad Periodontol ; 13(1): 17-26, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21387983

ABSTRACT

OBJECTIVE: To compare the clinical and microbiological effects of three protocols for nonsurgical periodontal therapy, including full-mouth scaling and root planing plus systemic antibiotics, on the treatment of chronic periodontitis patients. METHODS: Twenty-nine patients diagnosed with moderate to severe chronic periodontitis, selected according to specific criteria, were randomly assigned to one of three treatment groups: quadrant scaling, full-mouth scaling, and full-mouth scaling supplemented by systemic antibiotics. Antibiotic selection was based on the results of individual susceptibility testing. Oral hygiene instructions and reinforcement were given during the study. All patients received a clinical periodontal and microbiological examination at baseline and at reexamination, 4-6 weeks after therapy. Means and standard deviations were calculated and differences between groups were analyzed via the Kruskal-Wallis test, p < 0.05. RESULTS: The mean age of the study sample was 49.1 + 11.6 years old, and there were 17 men and 12 women. Patients treated with antibiotics showed antimicrobial susceptibility for amoxicillin and doxycycline. All study groups showed a similar significant improvement in periodontal parameters. Plaque scores were reduced in a range of 29.0% to 42.6%. Bleeding on probing was reduced by 34.8% to 55.0%; the reduction for the full-mouth scaling group was larger. Mean reduction in pocket depth was 1.2 to 1.3 mm in all groups. Mean bacterial counts were reduced in the groups receiving full-mouth treatment, but not in the quadrant treatment group. CONCLUSION: The three protocols for non-surgical periodontal treatment demonstrated a similar positive effect on clinical parameters; however, only full-mouth treatment groups showed a reduction in anaerobic microbial counts at re-examination.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Bacteria, Anaerobic/drug effects , Chronic Periodontitis/therapy , Dental Scaling/methods , Adult , Amoxicillin/pharmacology , Amoxicillin/therapeutic use , Anti-Bacterial Agents/pharmacology , Colony Count, Microbial , Dental Plaque Index , Doxycycline/pharmacology , Doxycycline/therapeutic use , Female , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Periodontal Index , Statistics, Nonparametric
SELECTION OF CITATIONS
SEARCH DETAIL